Johnson and Johnson (J&J) announced on Tuesday that its total sales in the first quarter of fiscal 2025 amounted to $21.9 billion, marking a 2.4% increase compared to the same period a year prior. The figure came in above the market expectations.

The company's diluted earnings per share skyrocketed by 238.8% year-over-year to land at $4.54 in the reported trimester. Meanwhile, its net earnings stood at $11 billion, up 237.9% from the same quarter a year before.

"The power of Johnson & Johnson’s uniquely diversified portfolio was on full display this quarter, with strong operational sales growth reinforcing our confidence in 2025 guidance," Chairman and CEO Joaquin Duato commented. The company's stock added 0.43% during the premarket trade, selling at $155.03 apiece.